MD Medical Group announces it has received a primary listing status on the Moscow Exchange

7 November 2023 – MD Medical Group Investments Plc (“MD Medical Group”, “MDMG”, the “Group” or the “Company” – MOEX: MDMG), a leading Russian private healthcare provider, today announces about the receiving the primary listing status on the Moscow Exchange.

On 7 November 2023 the Bank of Russia registered the prospectus of the Company's Global Depositary Receipts (hereinafter - the “GDRs”) in accordance with the Regulation No. 714-P dated 03.27.2020 of the Bank of Russia and the Directive No. 5951-U dated 09.29.2021 of the Bank of Russia and admit the existing GDRs to public circulation in the Russian Federation. Herewith the Company has finalized the procedure of changing the listing status on the Moscow Exchange to primary.

In 2012, MD Medical Group received a primary listing on the main market of the London Stock Exchange (hereinafter - “LSE”). Since 2020, the Company's GDRs are traded on the main market of the Moscow Exchange under the ticker MDMG and are included in the First Level quotation list.

On 22 June 2023, following Company’s application, the Company’s GDRs were cancelled from the UK Financial Conduct Authority’s official list and admission to trading on the LSE but continued trading on the regulated market of the Moscow Exchange.

The change of the listing status to primary does not create any restrictions for the Company’s GDRs trading and does not require any additional actions from the holders of MDMG’s GDRs.           

About MD Medical Group

MD Medical Group is a leading provider in the highly attractive Russian private healthcare service market. Today, the Company manages 53 state-of-the-art healthcare facilities, including 10 multidisciplinary hospitals and 43 out-patient clinics in 27 regions of the Russian Federation. In 2022, MD Medical Group's revenue amounted to RUB 25.2 bln while EBITDA amounted to RUB 7.9 bln. The Company's GDRs are traded on Moscow Exchange (MOEX: MDMG).